Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of HCQS Hydroxychloroquine Tablets IP 400 mg
HCQS Hydroxychloroquine Tablets IP 400 mg is an antimalarial medication commonly used to treat and prevent malaria. In addition to its antimalarial properties, it is also prescribed for autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE) due to its immunomodulatory effects.
Uses of HCQS Hydroxychloroquine Tablets IP 400 mg
Malaria Prevention and Treatment: Effective against malaria caused by Plasmodium vivax, Plasmodium malariae, and sensitive strains of Plasmodium falciparum.
Rheumatoid Arthritis: Reduces inflammation, pain, and joint damage associated with rheumatoid arthritis.
Systemic Lupus Erythematosus (SLE): Manages symptoms and flares of lupus, including skin rashes, joint pain, and fatigue.
Discoid Lupus Erythematosus: Treats chronic skin conditions associated with lupus.
Benefits of HCQS Hydroxychloroquine Tablets IP 400 mg
Versatile Medication: Effective in treating malaria and autoimmune diseases.
Reduces Inflammation: Alleviates symptoms of rheumatoid arthritis and lupus.
Prevents Disease Flares: Helps manage and prevent flares in autoimmune conditions.
Immunomodulatory Effects: Modulates the immune system to reduce autoimmune responses.
Improves Quality of Life: Enhances daily functioning by reducing disease symptoms.
Mechanism of Action of HCQS Hydroxychloroquine Tablets IP 400 mg
Hydroxychloroquine works by interfering with the growth and replication of the malaria parasite in red blood cells. For autoimmune diseases, it modulates the immune system by inhibiting certain cellular functions and inflammatory responses, reducing the activity of the immune system against the body's own tissues.